Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as an antimalarial strategy.

Research square·2024
Same author

The Novel bis-1,2,4-Triazine MIPS-0004373 Demonstrates Rapid and Potent Activity against All Blood Stages of the Malaria Parasite.

Antimicrobial agents and chemotherapy·2021
Same author

Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious Antimalarials.

Journal of medicinal chemistry·2021
Same author

Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as <i>Plasmodium</i> Cytoplasmic Prolyl-tRNA Synthetase Inhibitors.

ACS infectious diseases·2021
Same author

A Plasmodium vivax experimental human infection model for evaluating efficacy of interventions.

The Journal of clinical investigation·2020
Same author

Orthoscuticellines A-E, β-Carboline Alkaloids from the Bryozoan <i>Orthoscuticella ventricosa</i> Collected in Australia.

Journal of natural products·2020

Related Experiment Video

Updated: May 16, 2026

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
12:22

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput

Published on: September 22, 2019

Whole-cell in vitro screening for gametocytocidal compounds.

Leonardo Lucantoni1, Vicky Avery

  • 1Discovery Biology, Eskitis Institute for Cell & Molecular Therapies, Griffith University, Nathan, Queensland, Australia.

Future Medicinal Chemistry
|December 14, 2012
PubMed
Summary

Discovering new compounds to inhibit Plasmodium falciparum sexual stages is crucial for malaria transmission blocking. This review covers gametocytocidal assay development and challenges for malaria eradication.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing &#946;-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Related Experiment Videos

Last Updated: May 16, 2026

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
12:22

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput

Published on: September 22, 2019

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing &#946;-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Drug Discovery

Background:

  • Urgent need for novel antimalarial compounds targeting Plasmodium falciparum sexual stages to block malaria transmission.
  • Existing antimalarial drug discovery efforts primarily focus on asexual stages, necessitating new strategies for transmission-blocking therapies.
  • Global malaria eradication requires the development of new therapeutic combinations, including transmission-blocking agents.

Purpose of the Study:

  • To discuss the challenges associated with large-scale culturing of Plasmodium falciparum gametocytes for drug screening.
  • To review the current state-of-the-art in gametocytocidal assay development for identifying transmission-blocking compounds.
  • To highlight the importance of these assays in the discovery of new chemical starting points for malaria elimination.

Main Methods:

  • Review of recently published stage-specific methodologies for assessing compound activity against in vitro cultured gametocytes.
  • Analysis of challenges in high-throughput gametocyte culturing and assay development.
  • Examination of screening data from large chemical libraries against parasite asexual and sexual stages.

Main Results:

  • Public availability of focused subsets of known antimalarial actives from asexual stage screening provides starting points for gametocytocidal compound identification.
  • Advancements in stage-specific methodologies have improved throughput for assessing compound activity against gametocytes.
  • Significant challenges remain in optimizing large-scale gametocyte culturing for robust assay development.

Conclusions:

  • Developing effective gametocytocidal compounds is essential for malaria transmission blocking and eventual eradication.
  • Continued innovation in gametocytocidal assay development and high-throughput culturing is critical for accelerating drug discovery.
  • Leveraging existing antimalarial knowledge and screening platforms can expedite the identification of new therapeutic leads for malaria elimination.